Ian Read - Pfizer

Ian Read - Pfizer
Total Compensation: $25 million

Details: Read is a new face on this list, after former CEO Jeffrey Kindler's surprise resignation put him at the head of the pharma giant. That promotion brought with it a 44% pay increase, with Read's $1.7 million base salary, $3.5 million cash bonus, stock awards and benefits adding up to $25 million in 2011.

Under his stewardship, however brief, Pfizer ($PFE) has exceeded its financial goals, the company reported, and Read's vision for the future involves streamlining some of the company's operations. For starters, Read pledged to cut $1 billion from the company's budget, including $1.5 million from the company's R&D department, dropping 4,200 employees in the process. Earlier this year, Pfizer cut its severance package for workers, and the company is planning to sell its nutrition unit to Nestlé for a reported $9 billion.

Ian Read - Pfizer

Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

Novartis and Incyte will put their blockbuster JAK inhibitor into phase 3 clinical trials as a possible treatment for COVID-19, the drugmakers said.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.